Inmagene to join Nasdaq through reverse merger with Ikenanews2024-12-23T14:55:44+00:00December 23rd, 2024|Endpoints News|
FDA approves Lilly weight loss drug Zepbound for sleep apneanews2024-12-23T14:27:20+00:00December 23rd, 2024|Endpoints News|
Novo Nordisk’s once-daily hemophilia drug Alhemo is approvednews2024-12-23T12:52:19+00:00December 23rd, 2024|Endpoints News|
Vertex gets ‘vanza triple’ approval and Trikafta expansionnews2024-12-23T02:56:01+00:00December 23rd, 2024|Endpoints News|
2024’s biopharma winners and losers; CagriSema falls short; Merck swings China GLP-1 deal; and morenews2024-12-21T11:00:31+00:00December 21st, 2024|Endpoints News|
PBM changes unlikely to join spending bill as shutdown loomsnews2024-12-20T20:17:15+00:00December 20th, 2024|Endpoints News|
Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patientsnews2024-12-20T20:05:59+00:00December 20th, 2024|Endpoints News|
FDA’s Califf predicts Ramaswamy-RFK battle over agencynews2024-12-20T19:20:44+00:00December 20th, 2024|Endpoints News|
Rhythm receives expanded approval for genetic obesity drugnews2024-12-20T19:17:04+00:00December 20th, 2024|Endpoints News|
FDA approves Humacyte’s lab-grown blood vesselsnews2024-12-20T18:53:56+00:00December 20th, 2024|Endpoints News|
